Can Ali Ağca

6PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 13, 2026
Hydroxytyrosol suppressed the nephrotoxicity of cisplatin while supporting its therapeutic potential in a rat model of hepatocellular carcinoma.

|Apr 17, 2026
STAT3 inhibitor STAT-IN-12 induces apoptosis in mutant-p53 MDA-MB-435 and MDA-MB-231 breast cancer cell lines.

|Jan 10, 2026
Resveratrol potentiates chemotherapeutic efficacy of olaparib in MCF7 human breast cancer cells by inducing apoptosis.

Mehmet Kadir Erdoğan, Ramazan Gundogdu, Yusuf Toy

|Nov 26, 2025
Deciphering the Anti-Cancer Efficacy of the Combination of Small-Molecule Inhibitor KAN0438757 and Curcumin in Lung Cancer Cell Lines.

Deniz Özdemir, Can Ali Ağca

|Apr 24, 2024
The Effect of Thymoquinone on the TNF-α/OTULIN/NF-κB Axis Against Cisplatin-İnduced Testicular Tissue Damage.

Tuba Yalçın, Sercan Kaya, Akın Yiğin

|Jul 26, 2021
Quercetin and Luteolin Improve the Anticancer Effects of 5-Fluorouracil in Human Colorectal Adenocarcinoma In Vitro Model: A Mechanistic Insight.

Mehmet Kadir Erdoğan, Can Ali Ağca, Hakan Aşkın

Pageof 1

Frequent Collaborators

3 joint publications

Deniz Özdemir

2 joint publications

Mehmet Kadir Erdoğan

2 joint publications

Tuba Yalçın

2 joint publications

Sercan Kaya